The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The vaccine contract manufacturing market will likely increase from $3 billion in 2022 to $3.30 billion in 2023, with a 10% CAGR. By 2027, the market is projected to reach $4.78 billion, growing at a 9.7% CAGR.

North America held the largest vaccine contract manufacturing market share, and Asia-Pacific was the fastest-growing region in 2022.

Vaccine Contract Manufacturing Market Driver
Growing support for vaccinations is expected to drive vaccine contract manufacturing market growth. Vaccination, an efficient defense against contagious diseases, enhances immunity and shields against infections. Increased vaccination initiatives promote advancements in vaccine manufacturing processes, benefiting contract manufacturing. In November 2022, the US Department of Health and Human Services introduced a $350 million initiative for HRSA-supported health facilities, focusing on marginalized communities, to increase COVID-19 vaccine availability, fueling market growth.

View More On The Vaccine Contract Manufacturing Market Report 2023 – https://www.thebusinessresearchcompany.com/report/vaccine-contract-manufacturing-global-market-report

Prominent Vaccine Contract Manufacturing Market Trend
Strategic alliances are a prominent trend in the vaccine contract manufacturing market. Major firms collaborate with industry players to maintain their market position. For example, in January 2023, Australia’s Vaxxas, a biotech company, partnered with Norway’s Coalition for Epidemic Preparedness Innovations to support vaccine development and Vaxxas’ needle-free vaccine patch technology, aiming to eliminate mRNA vaccine frozen storage requirements. In January 2021, Switzerland’s Novartis, a player in the vaccine contract manufacturing market, teamed up with US-based Pfizer and Germany’s BioNTech to provide manufacturing capacity for the Pfizer-BioNTech COVID-19 vaccine, facilitating bulk mRNA ingredient filling into vials for distribution.

Vaccine Contract Manufacturing Market Prominent Players
Major players in the vaccine contract manufacturing market are Pfizer Inc, Johnson & Johnson, AbbVie Inc., Sanofi, GlaxoSmithKline, Merck KGaA, Fujifilm Holdings Corporation, Moderna, BioNTech, GSK Vaccines, AstraZeneca PLC, Ajinomoto Co. Inc., Icon plc, Lonza Group AG, Cytiva, Catalent Inc., Charles River Laboratories International Inc., Serum Institute of India Pvt. Ltd, Samsung Biologics, WuXi Biologics, Novavax, Sinovac Biotech, Emergent BioSolutions Inc., Albany Molecular Research Inc., Soligenix Inc., Bio Farma, Curia Global Inc., Hualan Biological Engineering, BioMARC, Bavarian Nordic A/S, AGC Biologics, IDT Biologika GmbH, Bharat Biotech, Goodwin Biotechnology Inc., and Biofabri S.L.

Request A Sample Of The Global Vaccine Contract Manufacturing Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12216&type=smp

Key Vaccine Contract Manufacturing Market Segments
The global vaccine contract manufacturing market is segmented –
1) By Service Type: Fill-Finish, Bulk Product
2) By Vaccine Type: Inactivated Vaccines, Live-Attenuated Vaccines, RNA (Ribonucleic Acid) Vaccines, Subunit Vaccines, Toxoid-Based Vaccines
3) By Process: Downstream, Upstream
4) By Scale Of Operation: Preclinical, Clinical, Commercial
5) By End-Use: Human Use, Veterinary

The Vaccine Contract Manufacturing Global Market Report 2023  provides a comprehensive overview on the vaccine contract manufacturing market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the vaccine contract manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Contract Development Manufacturing Organizations Global Market Report 2023
Manufacturing Execution System Global Market Report 2023
Vaccine Adjuvants Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model